ArticleBJU international2015

A phase I study of TRC105 anti-endoglin (CD105) antibody in metastatic castration-resistant prostate cancer.

Fatima H Karzai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.